These patients have a high incidence of malignancies (40%) mainly of chondrosarcoma, but also glioma, fibrosarcoma, and angiosarcoma.10 Lesions have IDH1 or IDH2 gene mutations (Figure 2B4).12 The gene discussed is IDH2; the disease is central nervous system cancer.